High blood pressure drug trial halted after just one patient
NCT ID NCT06780033
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This was a very early Phase 1 study testing a single injection of ART101 in people with high blood pressure. The trial was stopped after only 1 participant was enrolled, so no meaningful results are available. The goal was to check safety and how the drug moves through the body.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ART101 (injected drug)
What this could lead to
If successful, ART101 could offer a new way to lower blood pressure with a single injection.
What could go wrong
This was a very early Phase 1 trial that was terminated after only 1 participant. It is too small and incomplete to draw any conclusions about safety or effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX Clinical Research Central
Adelaide, South Australia, 5000, Australia
-
CMAX Clinical Research Fusion
Norwood, South Australia, 5067, Australia
-
University of Sunshine Coast
Morayfield, Queensland, 4506, Australia